Clinical Trial Update: Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

View source ↗

Summary

Ultragenyx is conducting a disease monitoring program for Glycogen Storage Disease Type Ia, and the study is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Ia

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Glycogen Storage Disease Type Ia | Status: RECRUITING